share_log

Midday ETF Review | The CNI Biomedicine Index Sector is up across the board, with the Hwabao WP CSI Medical Service ETF rising by 2%

Gelonghui Finance ·  Jul 25, 2025 11:39

Gelonghui, July 25 | The three major A-share indices collectively fell in the morning session. As of midday, the Shanghai Composite Index (SCI) dropped by 0.34%, the Shenzhen Component Index (SZCI) fell by 0.29%, and the Growth Enterprise Market (GEM) Index declined by 0.32%. The CSI CNI Biomedicine Index rose by 0.45%. The half-day trading volume for the Shanghai, Shenzhen, and Beijing markets was RMB 1124.1 billion, a decrease of RMB 8.9 billion from the previous day. Over 3,000 stocks across the All Market fell. In terms of sectors, the Sora Concept, medical devices, cloud computing, the Pet Economy, and logistics sectors were among the top gainers; the Hainan Free Trade Zone, Yaxia Hydropower, liquor, and rare earth permanent magnet sectors saw the largest declines. In the ETFs, the CNI Biomedicine Index sector saw a broad rally, with the Yongying Fund's Hong Kong Medical ETF, Huabao Fund's Hong Kong Innovation Drug ETF, Hwabao WP CSI Medical Service ETF, and HSBC's Medical Devices ETF increasing by 2.08%, 1.47%, 1.41%, and 1.38% respectively. Commodity futures generally rose, with the Energy and Chemical Industry ETF of Jianxin Funds up by 1.64%. The AI application sector also saw gains, with the E Fund Artificial Intelligence ETF and Huabao Fund's Sci-Tech Innovation Artificial Intelligence ETF rising by 1.15% and 1.12% respectively. The cloud computing sector continued to rise, with the GF Cloud Computing 50 ETF up by 0.99%. The building materials and infrastructure sectors led the declines, with the E Fund Building Materials ETF, Infrastructure ETF, and ZIYUANETF all down by 2%. Network Technology stocks in Hong Kong retreated, with the Hang Seng Internet and Tech ETF and the Hang Seng Internet ETF falling by 2.15% and 2.05% respectively.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment